Andover, Mass., and Diamond Bar, Calif., USA Royal Philips Electronics and Biosense Webster, Inc. announced today that they have signed an agreement to co-develop integrated products that will simplify complex procedures to diagnose and treat irregular heartbeats, also known as arrhythmias.

This strategic alliance will enable the creation of an integrated Allura Xper electrophysiology (EP) Lab System, as well as with Philips Xcelera Cardiovascular Information Solution. The interface between the Carto System and Allura Xper Integrated EP Lab can help reduce the amount of time required to setup and perform complex electrophysiology (EP) ablation procedures, which are designed to restore normal heart rhythms. The joint development program will also help by creating easier storage and retrieval of imaging data, allowing physicians to review and report from a single system.

The agreement with Biosense Webster is an important next step for Philips dedicated EP business program. We are committed to improving the lab environment, enabling new, more complex procedures, and integrating the EP workflow process across the complete patient care cycle," said Ronald Tabaksblat, vice president, electrophysiology, for Philips Medical Systems. Philips relationship with Biosense Webster demonstrates our strategy of collaborating with best-in-class companies to develop comprehensive EP product offerings. It promotes our vision of leading the EP market through better, simpler treatment solutions.

This agreement underscores Biosense Webster's commitment to empower electrophysiologists and foster health in patients around the world who suffer from irregular heartbeats,said Roy Tanaka, president, Biosense Webster. By integrating our systems with Philips, we will further improve the quality of care that EP labs provide.